Journal Article

Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation

Liu, Jinfeng, Zindal, Anuradha, Fairbrother, Wayne J., Popovych, Nataliya, Kolumam, Ganesh, Dixit, Vishva M., Lee, Wyne P., Newton, Kim, Wertz, Ingrid E., Tom, Jeffrey, Zhang, Juan, Warming, Søren, Dueber, Erin, Kategaya, Lorna, Quan, Clifford, Caplazi, Patrick, Kusam, Saritha, Sandoval, Wendy, Schoeffler, Allyn, Horikawa, Keisuke, Balazs, Mercedesz, Ramamoorthi, Nandhini, Mukund, Susmith, Yu, Kebing, Lam, Cynthia, Jeet, Surinder, Newman, Robert J., Seshasayee, Dhaya, Helgason, Elizabeth, Martin, Flavius, DeVoss, Jason, Dugger, Debra, Goodnow, Christopher C., Townsend, Michael

2015

Overview

Inactivation of the TNFAIP3 gene, encoding the A20 protein, is associated with critical inflammatory diseases including multiple sclerosis, rheumatoid arthritis and Crohn’s disease. However, the role of A20 in attenuating inflammatory signalling is unclear owing to paradoxical in vitro and in vivo findings. Here we utilize genetically engineered mice bearing mutations in the A20 ovarian tumour (OTU)-type deubiquitinase domain or in the zinc finger-4 (ZnF4) ubiquitin-binding motif to investigate these discrepancies. We find that phosphorylation of A20 promotes cleavage of Lys63-linked polyubiquitin chains by the OTU domain and enhances ZnF4-mediated substrate ubiquitination. Additionally, levels of linear ubiquitination dictate whether A20-deficient cells die in response to tumour necrosis factor. Mechanistically, linear ubiquitin chains preserve the architecture of the TNFR1 signalling complex by blocking A20-mediated disassembly of Lys63-linked polyubiquitin scaffolds. Collectively, our studies reveal molecular mechanisms whereby A20 deubiquitinase activity and ubiquitin binding, linear ubiquitination, and cellular kinases cooperate to regulate inflammation and cell death. The authors define molecular mechanisms by which distinct domains of the ubiquitin editing enzyme A20 contribute to the regulation of inflammation and cell death. Anti-apoptotic/anti-inflammatory actions of protein A20 Compromised function of the ubiquitin-editing enzyme A20 contributes to various inflammatory syndromes and autoimmune diseases including rheumatoid arthritis, multiple sclerosis, Crohn's disease and psoriasis. Here Ingrid Wertz et al . define the molecular mechanisms by which distinct domains of A20 contribute to the regulation of inflammation and cell death.

• Publisher: Nature Publishing Group UK,Nature Publishing Group
• Subject: 631/250/1933 / 631/250/38 / Animals / Autoimmune diseases / Care and treatment / Cell Death / Control / Cysteine Endopeptidases - chemistry / Cysteine Endopeptidases - genetics / Cysteine Endopeptidases - metabolism / Development and progression / Female / Genetic aspects / Genetically modified organisms / Humanities and Social Sciences / Inactivation / Inflammation / Inflammation - genetics / Inflammation - metabolism / Inflammation - pathology / Intracellular Signaling Peptides and Proteins - chemistry / Intracellular Signaling Peptides and Proteins - genetics / Intracellular Signaling Peptides and Proteins - metabolism / Kinases / Lysine - metabolism / Male / Methods / Mice / Mice, Inbred C57BL / multidisciplinary / Mutation / Phosphorylation / Polyubiquitin - chemistry / Polyubiquitin - metabolism / Protein Binding / Protein Kinases - metabolism / Proteins / Rheumatoid arthritis / Science / Scientific imaging / Signal Transduction / Tumor Necrosis Factor alpha-Induced Protein 3 / Tumor Necrosis Factor-alpha - metabolism / Tumor necrosis factor-TNF / Ubiquitin / Ubiquitin - chemistry / Ubiquitin - metabolism / Ubiquitination